RAPT THERAPEUTICS INC (RAPT) Institutional Ownership
None of the superinvestors we track currently report RAPT THERAPEUTICS INC (RAPT) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in RAPT THERAPEUTICS INC (RAPT), this page will show institutional holding trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q1 2025 | 1 | $791,564 | 648,823 |
| Q4 2024 | 1 | $584,183 | 369,736 |
| Q3 2024 | 1 | $592,146 | 294,600 |
| Q2 2024 | 1 | $621,895 | 203,900 |
| Q1 2024 | 1 | $880 | 98,000 |
| Q2 2023 | 1 | $959 | 51,300 |
| Q1 2023 | 1 | $1,991 | 108,500 |
| Q4 2022 | 1 | $640 | 32,300 |
| Q3 2022 | 1 | $715 | 29,700 |
| Q1 2022 | 1 | $1,001 | 45,500 |
| Q4 2021 | 1 | $694 | 18,900 |
| Q3 2021 | 1 | $1,186 | 38,200 |
Related RAPT Institutional Insights:
- RAPT Institutional Ownership & Insiders Activity
- RAPT Institutional Ownership & 13F Activity
- RAPT Top Institutional Shareholders
- RAPT Institutional Buying Activity
- RAPT Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- RAPT Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings